Stock Track | Pacira Pharmaceuticals (PCRX) Plunges 5.03% on Monday Amid Class Action Lawsuit

Stock Track

2025/03/04

Pacira Pharmaceuticals (PCRX) stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.

According to the report, a class action lawsuit was filed against Pacira Biosciences, Inc. (PCRX) by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.

The market reacted negatively to the news, as investors seemingly expressed concern over the potential implications of the lawsuit on the company's operations and financial performance. The stock experienced a significant sell-off, resulting in a 5.03% decline in its share price on Monday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1195156426"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195156426\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195156426?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-04 04:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195156426","market":"us","top_or_hot":-1,"title":"Stock Track | Pacira Pharmaceuticals (PCRX) Plunges 5.03% on Monday Amid Class Action Lawsuit","media":"Stock Track","content":"<p>Pacira Pharmaceuticals (PCRX) stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.</p>\n\n<p>According to the report, a class action lawsuit was filed against Pacira Biosciences, Inc. (PCRX) by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.</p>\n\n<p>The market reacted negatively to the news, as investors seemingly expressed concern over the potential implications of the lawsuit on the company's operations and financial performance. The stock experienced a significant sell-off, resulting in a 5.03% decline in its share price on Monday.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Pacira Pharmaceuticals (PCRX) Plunges 5.03% on Monday Amid Class Action Lawsuit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Pacira Pharmaceuticals (PCRX) Plunges 5.03% on Monday Amid Class Action Lawsuit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-04 04:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pacira Pharmaceuticals (PCRX) stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.</p>\n\n<p>According to the report, a class action lawsuit was filed against Pacira Biosciences, Inc. (PCRX) by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.</p>\n\n<p>The market reacted negatively to the news, as investors seemingly expressed concern over the potential implications of the lawsuit on the company's operations and financial performance. The stock experienced a significant sell-off, resulting in a 5.03% decline in its share price on Monday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PCRX","symbol_name":"Pacira Pharmaceuticals","start_time":0,"source_url":"","article_id":"1195156426","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195156426","pubTimestamp":1741034800,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Pacira Pharmaceuticals  stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.According to the report, a class action lawsuit was filed against Pacira Biosciences, Inc.  by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.The market reacted negatively to the news, as investors seemingly expressed concern over the","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PCRX":"Pacira Pharmaceuticals"},"translate_title":"股票追踪Pacira Pharmaceuticals(PCRX)周一因集体诉讼暴跌5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PCRX":1},"content_text":"Pacira Pharmaceuticals (PCRX) stock plummeted 5.03% on Monday, following the news of a class action lawsuit filed against the company.\nAccording to the report, a class action lawsuit was filed against Pacira Biosciences, Inc. (PCRX) by Levi & Korsinsky on January 13, 2025. The lawsuit alleges certain claims against the company and its executives, potentially posing legal and financial risks for Pacira Pharmaceuticals.\nThe market reacted negatively to the news, as investors seemingly expressed concern over the potential implications of the lawsuit on the company's operations and financial performance. The stock experienced a significant sell-off, resulting in a 5.03% decline in its share price on Monday.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}